Mylan to Offer Some Patients Aid on Cost of EpiPens

August 25, 2016 11:26 PM

15 0

Mylan to Offer Some Patients Aid on Cost of EpiPens

Heather Bresch, chief executive of Mylan, discusses the controversy surrounding the recent 400-percent increase in her company’s life-saving allergy injector.

Responding to a growing furor from consumers and politicians, the pharmaceutical company Mylan said on Thursday that it would lower the out-of-pocket costs to some patients who need EpiPens, which are used to treat life-threatening allergy attacks.

Also read: Our Profiteering Health Insurance Industry: Should The Government Bail It Out Again?

Read more

To category page

Loading...